Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
194 hedge funds and large institutions have $4.62B invested in Syneos Health, Inc. Class A Common Stock in 2017 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 73 increasing their positions, 68 reducing their positions, and 83 closing their positions.
622% more call options, than puts
Call options by funds: $3.43M | Put options by funds: $475K
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
7% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 68
15% less capital invested
Capital invested by funds: $5.46B → $4.62B (-$836M)
18% less funds holding
Funds holding: 238 → 194 (-44)
51% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 83
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$78.3M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$72.8M |
| 3 |
JP
Jana Partners
New York
|
+$61.7M |
| 4 |
HSC
Harbor Spring Capital
New York
|
+$53.4M |
| 5 |
ClearBridge Investments
New York
|
+$43.5M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$74.2M |
| 2 |
HM
HealthCor Management
New York
|
-$48.7M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$43.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$37.9M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$32.1M |
SYNH Hedge Fund Activity: Q4 2017 in Review
194 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q4 2017, worth a combined $4.62B — down 15% from $5.46B a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of SYNH and 41 opened new positions — a net loss of 42 holders — while 68 trimmed existing stakes and 73 added.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $78.3M. The largest seller was Vanguard Group, cutting an estimated $74.2M.
- 194 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q4 2017, down from 238 in Q3 2017.
- Funds reported $4.62B of Syneos Health, Inc. Class A Common Stock stock for Q4 2017, down 15% quarter-over-quarter.
- 41 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q4 2017 and 83 closed out, a net change of -42 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q4 2017 was Balyasny Asset Management, an estimated $78.3M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q4 2017 was Vanguard Group, an estimated $74.2M sold.
Based on aggregated 13F filings for Q4 2017.